Risk factors and post-resection independent predictive score for the recurrence of hepatitis B-related hepatocellular carcinoma by Lai, CL et al.
Title Risk factors and post-resection independent predictive score forthe recurrence of hepatitis B-related hepatocellular carcinoma
Author(s)
Hung, IFN; Wong, DKH; Poon, RTP; Fong, DYT; Chui, AHW;
Seto, WK; Fung, JYY; Chan, ACY; Yuen, JCH; Tiu, R; Choi, O;
Lai, CL; Yuen, MF
Citation
The 20th Medical Research Conference, The University of Hong
Kong, Hong Kong, 17 January 2015. In Hong Kong Medical
Journal, 2015, v. 21 suppl. 1, p. 26, abstract no. 34
Issued Date 2015
URL http://hdl.handle.net/10722/217519
Rights Hong Kong Medical Journal. Copyright © Hong Kong Academyof Medicine Press.
RISK FACTORS AND POST-RESECTION INDEPENDENT PREDICTIVE 
SCORE FOR THE RECURRENCE OF HEPATITIS B–RELATED 
HEPATOCELLULAR CARCINOMA 
IFN Hung
1
, DKH Wong 
1,2
, RTP Poon
3
, DYT Fong
4
, AHW Chui
5
, WK Seto
1
, JYY Fung
1
, 
ACY Chan
3
, JCH Yuen 
1,2
, R Tiu
6
, O Choi
1
, CL Lai 
1,2
, MF Yuen 
1,2
 
 
1
Department of Medicine, 
2
State Key Laboratory for Liver Research, 
3
Department of 
Surgery, 
4
School of Nursing Studies, The University of Hong Kong, Queen Mary 
Hospital, Hong Kong; 
5
Quality & Safety Division, New Territories West Cluster, 
Hospital Authority, Hong Kong; 
6
Department of Clinical Oncology, The University of 
Hong Kong, Queen Mary Hospital, Hong Kong 
 
BACKGROUND: Independent risk factors associated with hepatitis B virus (HBV)–
related hepatocellular carcinoma (HCC) after resection remains unknown. An accurate 
risk score for HCC recurrence is lacking. 
 
METHODS: We prospectively followed up 200 patients who underwent liver resection 
for HBV-related HCC for at least 2 years. Demographic, biochemical, tumour, 
virological, and anti-viral treatment factors were analysed to identify independent risk 
factors associated with recurrence after resection and a risk score for HCC recurrence 
formulated. 
 
RESULTS: Two hundred patients (80% male) who underwent liver resection for HBV-
related HCC were recruited. One hundred patients developed HCC recurrence (median 
duration after resection, 52 weeks). Multivariate analysis identified that the presence of 
lymphovascular permeation (P<0.001; relative risk [RR]=2.63), microsatellite lesions 
(P<0.001; RR=2.56), preoperative HBV DNA of >20 000 IU/mL (P=0.028; RR=1.62) 
were independently associated with HCC recurrence. Antiviral treatment before (P=0.008; 
RR=0.07) and after (P=0.004; RR=0.55) resection was independently associated with 
lower risk of HCC recurrence. A post-resection independent predictive score (PRIPS) 
was derived and validated with sensitivity of 72.1% and 69.8% and specificity of 62.9% 
and 77%, to predict the 1- and 3-year risks for the HCC recurrence respectively with the 
hazard ratio of 2.71 (P<0.001). The area under the curve for the 1- and 3-year prediction 
were 0.69 and 0.78, respectively. 
 
CONCLUSIONS: Several tumour and virological factors were associated with a higher 
cumulative risk of HCC recurrence after resection. PRIPS was derived for more accurate 
risk assessment. Antiviral treatment reduced the risk of recurrence. 
